0,933  0,005  Antiinflammatory
0,922  0,003  Nitric oxide antagonist
0,878  0,003  Sensitization
0,805  0,016  Apoptosis agonist
0,735  0,010  Antileukemic
0,715  0,018  Antineoplastic (breast cancer)
0,699  0,020  Transcription factor NF kappa B inhibitor
0,683  0,005  Hepatic disorders treatment
0,666  0,004  Hepatoprotectant
0,652  0,009  Antineoplastic (melanoma)
0,659  0,023  Antineoplastic (lung cancer)
0,634  0,011  Bone diseases treatment
0,603  0,010  Antineoplastic (pancreatic cancer)
0,593  0,011  Antiosteoporotic
0,591  0,014  Immunosuppressant
0,567  0,003  Antifungal enhancer
0,553  0,004  Contraceptive
0,566  0,021  Respiratory analeptic
0,564  0,027  Antineoplastic (colorectal cancer)
0,562  0,026  Antineoplastic (colon cancer)
0,543  0,015  Antipsoriatic
0,545  0,021  Antineoplastic (ovarian cancer)
0,496  0,005  Antiacne
0,521  0,035  Antibacterial
0,502  0,020  Apoptosis antagonist
0,485  0,010  Antineoplastic (liver cancer)
0,500  0,033  Antipruritic, allergic
0,477  0,013  Antineoplastic enhancer
0,503  0,046  TNF expression inhibitor
0,464  0,008  Abortion inducer
0,466  0,022  Cardiovascular analeptic
0,447  0,009  Hair growth stimulant
0,463  0,026  AR expression inhibitor
0,441  0,006  Lipocortins synthesis antagonist
0,434  0,007  Antialcoholic
0,450  0,028  Analeptic
0,424  0,006  Sepsis treatment
0,416  0,004  Contraceptive female
0,420  0,017  Antiulcerative
0,411  0,010  Prostate disorders treatment
0,408  0,009  Antipruritic, non-allergic
0,424  0,026  Chemopreventive
0,433  0,036  Antifungal
0,432  0,037  CYP2C19 substrate
0,404  0,009  Pneumotoxic
0,412  0,020  Calcium channel activator
0,437  0,051  CYP2C9 substrate
0,385  0,013  Antineoplastic (squamous cell carcinoma)
0,381  0,009  Protein kinase stimulant
0,418  0,048  Prostate cancer treatment
0,370  0,004  Postmenopausal disorders treatment
0,423  0,057  CYP3A4 substrate
0,370  0,009  Antiviral (Influenza A)
0,396  0,036  Antioxidant
0,391  0,034  NOS2 expression inhibitor
0,366  0,015  UGT2B7 substrate
0,365  0,015  Antiviral (Influenza)
0,430  0,094  Caspase 9 stimulant
0,372  0,036  Antiprotozoal (Leishmania)
0,350  0,016  Prostatic (benign) hyperplasia treatment
0,377  0,045  Radioprotector
0,344  0,023  UGT1A4 substrate
0,370  0,053  Immunomodulator
0,333  0,016  Interferon gamma antagonist
0,341  0,028  UDP-glucuronosyltransferase substrate
0,329  0,018  Antineoplastic (carcinoma)
0,343  0,046  UGT2B4 substrate
0,347  0,053  Cardioprotectant
0,319  0,026  P-glycoprotein inhibitor
0,292  0,003  Hypercalcemia treatment
0,329  0,046  Antineoplastic (endocrine cancer)
0,334  0,057  Antiepileptic
0,339  0,067  ICAM1 expression inhibitor
0,325  0,063  NOS3 expression inhibitor
0,281  0,021  Diabetic nephropathy treatment
0,270  0,012  Antineoplastic antibiotic
0,264  0,007  Choleretic
0,305  0,051  Proliferative diseases treatment
0,273  0,022  UGT2B15 substrate
0,316  0,068  Antineoplastic (brain cancer)
0,272  0,026  Antiviral (Hepatitis)
0,337  0,099  Antiprotozoal
0,268  0,029  Neurotrophic factor enhancer
0,298  0,062  Antihypoxic
0,285  0,052  Antineoplastic (glioblastoma multiforme)
0,286  0,054  Cytotoxic
0,251  0,023  Interleukin 6 antagonist
0,289  0,061  Antineoplastic (glioma)
0,301  0,078  Sodium/bile acid cotransporter inhibitor
0,242  0,019  Antiviral (Hepatitis B)
0,286  0,065  Teratogen
0,242  0,023  UGT2B9 substrate
0,274  0,060  Angiogenesis stimulant
0,221  0,007  Actinic keratosis treatment
0,228  0,022  Protein-tyrosine phosphatase 1B inhibitor
0,271  0,065  Tumour necrosis factor alpha release inhibitor
0,220  0,016  Microtubule formation inhibitor
0,255  0,052  Antihypotensive
0,260  0,060  DNA synthesis inhibitor
0,212  0,013  Antispirochetal
0,261  0,063  Cytostatic
0,246  0,049  VCAM1 expression inhibitor
0,245  0,049  UGT1A1 substrate
0,215  0,020  Arachidonic acid antagonist
0,198  0,004  Anabolic
0,262  0,070  Antineoplastic (cervical cancer)
0,200  0,009  Aromatase inhibitor
0,251  0,060  Antiparasitic
0,238  0,049  Antihelmintic
0,257  0,070  Embryotoxic
0,221  0,034  Anesthetic
0,204  0,021  Farnesoid X receptor antagonist
0,196  0,014  Androgen antagonist
0,299  0,117  Antineoplastic (myeloid leukemia)
0,258  0,078  Chemoprotective
0,189  0,012  Contraceptive male
0,234  0,059  Carcinogenic
0,220  0,048  Antieczematic atopic
0,187  0,019  Sulfotransferase substrate
0,184  0,018  Antineoplastic alkaloid
0,204  0,039  Melanin inhibitor
0,201  0,038  Antirickettsial
0,206  0,044  Protein-tyrosine phosphatase inhibitor
0,187  0,027  Antieczematic
0,172  0,011  Ca2+-transporting ATPase inhibitor
0,258  0,102  CTGF expression inhibitor
0,200  0,044  Diuretic
0,161  0,011  UGT2B11 substrate
0,176  0,033  Topoisomerase I inhibitor
0,238  0,097  Spasmolytic
0,186  0,050  UGT2B10 substrate
0,142  0,007  5-Alpha-reductase inhibitor
0,226  0,092  Antineoplastic (sarcoma)
0,170  0,036  Adenylate cyclase stimulant
0,214  0,081  RNA-directed DNA polymerase inhibitor
0,136  0,003  Postcoital contraceptive
0,148  0,016  SULT1E1 substrate
0,147  0,017  Inducible nitric-oxide synthase inhibitor
0,140  0,011  T cell inhibitor
0,145  0,017  Paget's disease treatment
0,212  0,085  Antineoplastic (lymphoma)
0,234  0,108  Antineoplastic (multiple myeloma)
0,182  0,056  ATPase inhibitor
0,159  0,035  Growth stimulant
0,126  0,009  Androgen agonist
0,117  0,003  Vitamin D receptor antagonist
0,126  0,013  Na+ K+ transporting ATPase inhibitor
0,153  0,043  Antitussive
0,159  0,049  Skin whitener
0,285  0,177  Antidiabetic
0,285  0,177  Cyclophilin D inhibitor
0,144  0,042  Menstruation disorders treatment
0,231  0,130  GST M1-1 substrate
0,143  0,042  Carcinogenic, group 2B
0,125  0,025  Antibiotic
0,119  0,021  Antiprotozoal activity enhancer
0,242  0,147  Antiprotozoal (Plasmodium)
0,095  0,004  Parathyroid hormone antagonist
0,201  0,109  Antineoplastic (renal cancer)
0,263  0,172  Analgesic
0,167  0,079  Mutagenic
0,229  0,141  Cholesterol antagonist
0,104  0,016  Estrogen agonist
0,139  0,052  Vanilloid 1 agonist
0,152  0,067  Genotoxic
0,103  0,020  Ca(v)3.1 blocker
0,130  0,048  SULT1A1 substrate
0,131  0,049  Alcohol dehydrogenase substrate
0,156  0,074  Eye irritation, high
0,094  0,012  SULT2A1 substrate
0,117  0,038  Antihypermotility
0,080  0,006  Glucocorticoid antagonist
0,098  0,026  Narcotic antagonist
0,089  0,018  Cannabinoid CB2 receptor antagonist
0,082  0,012  Lipocortins synthesis agonist
0,087  0,018  Glutamate (mGluR6) antagonist
0,071  0,002  Progesterone receptor B antagonist
0,181  0,113  Antiviral (HIV)
0,121  0,056  Endometrios treatment
0,073  0,009  RNA-directed RNA polymerase stimulant
0,163  0,101  Non-steroidal antiinflammatory agent
0,107  0,048  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,149  0,091  Antiviral (Hepatitis C)
0,116  0,058  Mucolytic
0,221  0,164  FMO1 substrate
0,097  0,041  Transcription factor NF kappa B stimulant
0,164  0,109  CYP2B6 inhibitor
0,155  0,101  Toxic, respiratory center
0,076  0,021  Protein 50S ribosomal subunit inhibitor
0,220  0,166  GST A substrate
0,213  0,161  Antithrombotic
0,115  0,065  Estrogen antagonist
0,120  0,071  Carcinogenic, group 3
0,154  0,105  LDLR expression enhancer
0,060  0,012  Sphingosine 1-phosphate receptor 3 agonist
0,061  0,014  Progesterone antagonist
0,166  0,119  Antiparkinsonian, rigidity relieving
0,060  0,014  Microtubule stabilization
0,172  0,126  Antihypercholesterolemic
0,107  0,062  Expectorant
0,050  0,005  Progesterone agonist
0,092  0,047  Antiviral (Trachoma)
0,081  0,039  Antitreponemal
0,176  0,135  Peptidyltransferase inhibitor
0,148  0,107  Sedative
0,101  0,062  Estrogen receptor beta antagonist
0,082  0,046  Keratolytic
0,195  0,162  5 Hydroxytryptamine uptake stimulant
0,057  0,026  Anesthetic inhalation
0,165  0,136  Antineoplastic (non-small cell lung cancer)
0,064  0,035  Heme oxygenase stimulant
0,071  0,045  Anticholelithogenic
0,045  0,019  GABA uptake inhibitor
0,053  0,027  Potassium channel Kv1.3 blocker
0,033  0,009  CYP24 inhibitor
0,058  0,035  Pregnane X receptor antagonist
0,112  0,090  Antihyperlipoproteinemic
0,096  0,075  Skin irritative effect
0,104  0,082  Cholesterol synthesis inhibitor
0,161  0,139  UGT1A6 substrate
0,031  0,010  Hedgehog signaling activator
0,041  0,020  Estrogen receptor alpha agonist
0,188  0,169  Metabolic disease treatment
0,037  0,019  Tubulin agonist
0,165  0,147  Vascular (periferal) disease treatment
0,026  0,010  Corticosteroid-like
0,105  0,090  Shock treatment
0,018  0,004  Progesterone receptor A antagonist
0,073  0,061  Estrogen receptor alpha antagonist
0,019  0,008  Vitamin D receptor agonist
0,027  0,017  Toll-Like receptor 4 agonist
0,027  0,018  Retinoid X gamma receptor antagonist
0,058  0,050  Antimycoplasmal
0,031  0,023  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,088  0,081  Nitric-oxide synthase inhibitor
0,051  0,044  Sphingosine 1-phosphate receptor 5 agonist
0,035  0,029  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,031  0,025  Glutamate (mGluR3) agonist
0,017  0,011  Telomerase stimulant
0,091  0,086  Toll-Like receptor 4 antagonist
0,026  0,020  Nicotinic acid receptor 2 antagonist
0,036  0,031  Glutamate (mGluR8) agonist
0,085  0,080  Protease inhibitor
0,044  0,040  Aldosterone antagonist
0,006  0,002  Vitamin D-like
0,020  0,016  Retinoid X beta receptor antagonist
0,021  0,018  Retinoid X gamma receptor agonist
0,029  0,026  ATP citrate lysase inhibitor
0,021  0,019  Retinoic acid gamma receptor agonist
0,041  0,039  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor

